Patent 10301637 was granted and assigned to Cellectis on May, 2019 by the United States Patent and Trademark Office.
Materials and methods for making plants (e.g., Solanum varieties) with decreased levels of amylose are provided herein. The methods can include making mutations in the gene encoding granule bound starch synthase (GBSS), where the mutations are induced using a rare-cutting endonuclease.